Logo image of ABVC

ABVC BIOPHARMA INC (ABVC) Stock Fundamental Analysis

USA - NASDAQ:ABVC - US00091F3047 - Common Stock

2.92 USD
+0.12 (+4.29%)
Last: 11/14/2025, 8:00:00 PM
Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to ABVC. ABVC was compared to 531 industry peers in the Biotechnology industry. Both the profitability and financial health of ABVC have multiple concerns. ABVC has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

ABVC had negative earnings in the past year.
In the past year ABVC has reported a negative cash flow from operations.
In the past 5 years ABVC always reported negative net income.
ABVC had a negative operating cash flow in each of the past 5 years.
ABVC Yearly Net Income VS EBIT VS OCF VS FCFABVC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5M -10M -15M

1.2 Ratios

The Return On Assets of ABVC (-19.44%) is better than 76.27% of its industry peers.
Looking at the Return On Equity, with a value of -34.14%, ABVC is in the better half of the industry, outperforming 73.82% of the companies in the same industry.
Industry RankSector Rank
ROA -19.44%
ROE -34.14%
ROIC N/A
ROA(3y)-110.53%
ROA(5y)-101.93%
ROE(3y)-476.9%
ROE(5y)-372.11%
ROIC(3y)N/A
ROIC(5y)N/A
ABVC Yearly ROA, ROE, ROICABVC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2K -2K -4K -6K

1.3 Margins

ABVC has a Gross Margin of 63.76%. This is in the better half of the industry: ABVC outperforms 79.85% of its industry peers.
ABVC's Gross Margin has been stable in the last couple of years.
ABVC does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 63.76%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.89%
GM growth 5Y0.55%
ABVC Yearly Profit, Operating, Gross MarginsABVC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10K -20K -30K -40K -50K

More info and screens

1

2. Health

2.1 Basic Checks

ABVC does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ABVC has more shares outstanding
Compared to 5 years ago, ABVC has more shares outstanding
The debt/assets ratio for ABVC is higher compared to a year ago.
ABVC Yearly Shares OutstandingABVC Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
ABVC Yearly Total Debt VS Total AssetsABVC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

2.2 Solvency

ABVC has an Altman-Z score of -1.31. This is a bad value and indicates that ABVC is not financially healthy and even has some risk of bankruptcy.
ABVC has a Altman-Z score of -1.31. This is comparable to the rest of the industry: ABVC outperforms 54.05% of its industry peers.
A Debt/Equity ratio of 0.07 indicates that ABVC is not too dependend on debt financing.
ABVC has a worse Debt to Equity ratio (0.07) than 62.15% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF N/A
Altman-Z -1.31
ROIC/WACCN/A
WACC8.55%
ABVC Yearly LT Debt VS Equity VS FCFABVC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M

2.3 Liquidity

A Current Ratio of 0.63 indicates that ABVC may have some problems paying its short term obligations.
With a Current ratio value of 0.63, ABVC is not doing good in the industry: 91.90% of the companies in the same industry are doing better.
ABVC has a Quick Ratio of 0.63. This is a bad value and indicates that ABVC is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.62, ABVC is not doing good in the industry: 91.53% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.63
Quick Ratio 0.62
ABVC Yearly Current Assets VS Current LiabilitesABVC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 77.08% over the past year.
Looking at the last year, ABVC shows a very strong growth in Revenue. The Revenue has grown by 56.53%.
The Revenue has been decreasing by -6.15% on average over the past years.
EPS 1Y (TTM)77.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-168%
Revenue 1Y (TTM)56.53%
Revenue growth 3Y12.28%
Revenue growth 5Y-6.15%
Sales Q2Q%104.47%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-4.55%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ABVC Yearly Revenue VS EstimatesABVC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 1M 2M 3M 4M
ABVC Yearly EPS VS EstimatesABVC Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 -1 -2 -3 -4 -5

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

ABVC reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ABVC. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ABVC Price Earnings VS Forward Price EarningsABVC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ABVC Per share dataABVC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 -0.4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ABVC does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ABVC BIOPHARMA INC

NASDAQ:ABVC (11/14/2025, 8:00:00 PM)

2.92

+0.12 (+4.29%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-12 2025-11-12
Earnings (Next)04-13 2026-04-13/amc
Inst Owners1.56%
Inst Owner Change42.31%
Ins Owners8.21%
Ins Owner Change0%
Market Cap68.74M
Revenue(TTM)798.00K
Net Income(TTM)-4.12M
Analysts43.33
Price TargetN/A
Short Float %2.06%
Short Ratio4.33
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 86.14
P/FCF N/A
P/OCF N/A
P/B 5.7
P/tB 5.7
EV/EBITDA N/A
EPS(TTM)-0.22
EYN/A
EPS(NY)-0.47
Fwd EYN/A
FCF(TTM)-0.09
FCFYN/A
OCF(TTM)-0.09
OCFYN/A
SpS0.03
BVpS0.51
TBVpS0.51
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -19.44%
ROE -34.14%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 63.76%
FCFM N/A
ROA(3y)-110.53%
ROA(5y)-101.93%
ROE(3y)-476.9%
ROE(5y)-372.11%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.89%
GM growth 5Y0.55%
F-Score5
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.63
Quick Ratio 0.62
Altman-Z -1.31
F-Score5
WACC8.55%
ROIC/WACCN/A
Cap/Depr(3y)224.8%
Cap/Depr(5y)N/A
Cap/Sales(3y)8.76%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)77.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-168%
EPS Next Y-4.55%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)56.53%
Revenue growth 3Y12.28%
Revenue growth 5Y-6.15%
Sales Q2Q%104.47%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y27.76%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y51.34%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y51.23%
OCF growth 3YN/A
OCF growth 5YN/A

ABVC BIOPHARMA INC / ABVC FAQ

Can you provide the ChartMill fundamental rating for ABVC BIOPHARMA INC?

ChartMill assigns a fundamental rating of 1 / 10 to ABVC.


What is the valuation status for ABVC stock?

ChartMill assigns a valuation rating of 0 / 10 to ABVC BIOPHARMA INC (ABVC). This can be considered as Overvalued.


How profitable is ABVC BIOPHARMA INC (ABVC) stock?

ABVC BIOPHARMA INC (ABVC) has a profitability rating of 2 / 10.


How financially healthy is ABVC BIOPHARMA INC?

The financial health rating of ABVC BIOPHARMA INC (ABVC) is 1 / 10.